Clinical approach to discoloration in body hair in a Rottweiler dog

Abstract

Micanfin (Biocan-M®, Bioveta) is a new veterinary drug used successfully in the treatment and prophylaxis of dermetomycosis in dogs and cats. In this study, leukotrichia was determined after administration of Micanfin and the objective was to determine the diagnosis and treatment protocol of the case. The case was a male Rottweiler dog, aged four, weighing 35 kg, presented with alopecia at a special veterinary clinic. A routine clinical examination, skin scraping, and antibiogram-mycologic examination of the body fluids were performed. A hematological examination and the levels of some serum parameters were determined. At the end of mycologic examinations, while there was no reproduction, it was found that the serum zinc level was very low. It was detected after other laboratory examinations that the case was hypothyroidism. All the body hair, except for a small area locally returned to the original colour, decreased activity reported by the animal owner disappeared at the end of the zinc applications and the treatment performed for the hypothyroidism (Biocan-M®). In conclusion, it was determined that the Micanfin vaccine application had not caused any side effects such as leukotrichia and the case was hypothyroidism.

Keywords

• Rottweiler dog
• clinical approach
• dermetomycosis
• hypothyroidsm